ILLUCO Corporation Ltd.

ILLUCO Corporation Ltd. manufactures medical devices such as the ILLUCO system, IDS-1100C, and IDS-9100 units. Based on the available information, these devices appear to be designed for precision-based applications, most likely within imaging or diagnostic equipment categories. The exact clinical use is not specified, but their classification under EU Class I suggests they pose minimal risk and are typically used for non-invasive procedures or low-risk diagnostic tools.

ILLUCO Corporation Ltd. is based in South Korea. The company’s headquarters or primary operational location is in Korea, though the specific city or region is not provided in the available data.

Yes, ILLUCO Corporation Ltd.’s devices are listed in the EU’s eudamed registry. This database is used to track medical devices that have been placed on the market within the European Economic Area, ensuring transparency and traceability for regulatory oversight. Listing in eudamed is a requirement for devices marketed in the EU, particularly for Class I devices.

ILLUCO Corporation Ltd.’s devices are classified under EU Class I. This classification is assigned based on risk assessment criteria outlined in EU Medical Device Regulations (MDR) or In Vitro Diagnostic Regulation (IVDR). Class I devices are generally considered to pose the lowest risk and often include items like diagnostic tools, certain imaging devices, or non-invasive monitoring equipment, though the specific risk profile depends on the device’s intended use.